TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division October 17, 1997